Cognition Therapeutics In... (CGTX)

0.45

-0.00 (-1.08%)

At close: Mar 03, 2025, 12:44 PM

Cognition Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-25.79M	-21.4M	-11.72M	-7.84M	-4.84M
Depreciation & Amortization	252K	235K	93K	98K	81K
Stock-Based Compensation	4.35M	3.57K	5.18K	475.00	361.00
Other Working Capital	2.46M	149K	677K	3.43M	-292K
Other Non-Cash Items	318K	6.54M	383K	836K	494K
Deferred Income Tax	n/a	-6.54M	-416K	-70K	238K
Change in Working Capital	4.85M	-943K	2.84M	3.07M	570K
Operating Cash Flow	-16.02M	-18.53M	-3.63M	-3.43M	-3.1M
Capital Expenditures	-147K	-171K	-27K	-10K	-144K
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-171K	-27K	n/a	n/a
Investing Cash Flow	-147K	-171K	-27K	-10K	-144K
Debt Repayment	-811K	-1.4M	-268K	5.81M	2.83M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	1.62M	9.25M	-46K	-34K
Financial Cash Flow	4.52M	5.55M	53.2M	5.76M	2.79M
Net Cash Flow	-11.64M	-13.16M	49.53M	2.3M	-508K
Free Cash Flow	-16.16M	-18.7M	-3.66M	-3.44M	-3.24M